Epilepsy Therapeutics Market : Increasing Prevalence of Neurological Disorders Drives the Market by 2015 - 2021

Published By:Zion Market Research

Epilepsy Therapeutics Market : Increasing prevalence
of neurological disorders drives the market by 2015 2021

Contact Us:
4283, Express Lane, Suite 634-143,
Sarasota, Florida 34249, United States
Tel: +1-386-310-3803 GMT
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651


Epilepsy Therapeutics Market

Epilepsy is a chronic neurological disorder characterized by unpredictable seizures. Epilepsy is
the fourth most common neurological disorder that affects peoples of all age group. Seizures
may be classified as focal seizures, generalized seizures, and other seizures. Focal seizures are
the most common type of epilepsy which involves secondary generalized tonic/clonic seizures
(sGTCS) and complex partial seizures. Generalized seizures include myoclonic seizures, tonic
seizures, atonic seizures, absences, and clonic seizures. These seizures occur when neurons in
the brain or a group of nerve cells send wrong signals to the body.
Browse the full " Epilepsy Therapeutics Market" report
at https://www.zionmarketresearch.com/report/epilepsy-therapeutics-market
Treatment of epilepsies is done by using antiepileptic drugs (AEDs). Antiepileptic drugs are
segmented into two major categories namely first generation AEDs and second generation
AEDs. Selection of drugs is done by prescriber depending upon the type of seizure, part of brain
involved in epilepsy, age of patient.

Epilepsy Therapeutics Market
Epilepsy therapeutic drug market is mostly driven by increasing prevalence of neurological
disorders and technological advancements across many countries. Moreover, increasing
awareness about diagnostics and treatment of neurological disorders in global market also help
in driving the epileptic market growth. Non availability of medical facilities in poor and
developing countries can restrict or hinder the growth of epileptic therapeutic market over the